Note: This document contains side effect information about botulism immune globulin. Some dosage forms listed on this page may not apply to the brand name BabyBIG.
Applies to botulism immune globulin: parenteral powder for iv infusion.
Side effects include:
Erythematous rash.
For Healthcare Professionals
Applies to botulism immune globulin: intravenous powder for injection.
Cardiovascular
Very common (10% or more): Blood pressure increased (75%), pallor (28%), cardiac murmur (15%)
Common (1% to 10%): Tachycardia NOS, peripheral coldness
Postmarketing reports: Cardiac arrest, vascular collapse, hypotension, thromboembolism[Ref]
Respiratory
Very common (10% or more): Atelectasis (39%), rhonchi (34%), nasal congestion (18%), oxygen saturation decreased (17%), cough (13%), rales (13%), breath sounds decreased (10%)
Common (1% to 10%): Stridor, dyspnea NOS, tachypnea, respiratory arrest
Postmarketing reports: Apnea, acute respiratory distress syndrome, transfusion related acute lung injury, cyanosis, hypoxemia, pulmonary edema, bronchospasm[Ref]
Gastrointestinal
Very common (10% or more): Dysphagia (65%), loose stools (25%), vomiting (20%), abdominal distension (11%)
Postmarketing reports: Abdominal pain[Ref]
Dermatologic
Very common (10% or more): Dermatitis contact (24%), rash erythematous (22%)
Postmarketing reports: Stevens-Johnson syndrome, epidermolysis, erythema multiforme, bullous dermatitis[Ref]
Other
Very common (10% or more): Edema (18%), pyrexia (17%), body temperature decreased (16%)
Postmarketing reports: Rigors[Ref]
Metabolic
Very common (10% or more): Dehydration (10%)
Common (1% to 10%): Hyponatremia, metabolic acidosis[Ref]
Immunologic
Very common (10% or more): Otitis media (11%), pneumonia (11%)
Common (1% to 10%): Lower respiratory tract infection, oral candidiasis, urinary tract infection[Ref]
Local
Common (1% to 10%): Injection site reaction, injection site erythema[Ref]
Hematologic
Common (1% to 10%): Hemoglobin decreased, anemia
Postmarketing reports: Pancytopenia, leukopenia, hemolysis, positive direct antiglobulin (Coombs) test[Ref]
Nervous system
Postmarketing reports: Coma, loss of consciousness, seizures, tremor[Ref]
Hepatic
Postmarketing reports: Hepatic dysfunction[Ref]
Musculoskeletal
Postmarketing reports: Back pain[Ref]
Psychiatric
Very common (10% or more): Irritability (41%), agitation (10%)[Ref]